Laparoscopic Gastrectomy Plus D2 Lymphadenectomy is As Effective As Open Surgery in Terms of Long-term Survival: a Single-institution Study on Gastric Cancer

Overview

Journal World J Surg Oncol

Publisher Biomed Central

Specialties General Surgery
Oncology

Date 2021 Apr 8

PMID 33827589

Citations 4

Authors

Yawei Wang

Yan Wang

Wang Wu

Xiaofang Lu

Tailai An

Jiling Jiang

Affiliations

Soon will be listed here.

Abstract

Background: Laparoscopic surgery has been widely accepted to treat early-stage gastric cancer. However, it is still controversial to perform laparoscopic gastrectomy plus D2 lymphadenectomy for locally advanced gastric cancer. We performed the present study to compare the long-term outcomes of patients after laparoscopic or open gastrectomy plus D2 lymphadenectomy.

Methods: The clinicopathological data of 182 gastric cancer patients receiving gastrectomy plus D2 lymphadenectomy between January 2011 and December 2015 at Shenzhen Traditional Chinese Medicine Hospital were retrospectively retrieved. The overall survival (OS) and disease-free survival (DFS) of these 182 patients were compared. Then, the prognostic significance of positive lymph node ratio (LNR) was assessed.

Results: As a whole, OS (P = 0.789) and DFS (P = 0.672) of patients receiving laparoscopic gastrectomy plus D2 lymphadenectomy were not significantly different from those of patients receiving open surgery. For stage I patients, laparoscopic gastrectomy plus D2 lymphadenectomy was not significantly different from open surgery in terms of OS (P = 0.573) and DFS (P = 0.157). Similarly, for stage II patients, laparoscopic gastrectomy plus D2 lymphadenectomy was not significantly different from open surgery in terms of OS (P = 0.567) and DFS (P = 0.830). For stage III patients, laparoscopic gastrectomy plus D2 lymphadenectomy was not significantly different from open surgery in terms of OS (P = 0.773) and DFS (P = 0.404). Laparoscopic or open gastrectomy plus D2 lymphadenectomy was not proven by Cox regression analysis to be an independent prognostic factor for OS and DFS. High LNR was significantly associated with worse OS (P < 0.001) and DFS (P < 0.001). Surgical type did not significantly affect prognosis of patients with low LNR or survival of patients with high LNR.

Conclusions: For patients with gastric cancer, laparoscopic gastrectomy plus D2 lymphadenectomy was not inferior to open surgery in terms of long-term outcomes. LNR is a useful prognostic marker for GC patients.

Citing Articles

Evaluating the safety of robotic total gastrectomy with D2 lymphadenectomy for gastric cancer against the conventional laparoscopic approach: a systematic review and meta-analysis.

Kossenas K, Moutzouri O, Georgopoulos F J Robot Surg. 2025; 19(1):59.

PMID: 39899136 DOI: 10.1007/s11701-025-02219-2.

Long-term relative survival of patients with gastric cancer from a large-scale cohort: a period-analysis.

Zhang H, Yang W, Tan X, He W, Zhao L, Liu H BMC Cancer. 2024; 24(1):1420.

PMID: 39558281 PMC: 11571998. DOI: 10.1186/s12885-024-13141-5.

Laparoscopic versus open surgery for locally advanced and metastatic gastric cancer complicated with bleeding and/or stenosis: short- and long-term outcomes.

Khorobrykh T, Abdulkhakimov N, Agadzhanov V, Aghayan D, Kazaryan A World J Surg Oncol. 2022; 20(1):216.

PMID: 35752852 PMC: 9233806. DOI: 10.1186/s12957-022-02674-3.

A novel nomogram based on cardia invasion and chemotherapy to predict postoperative overall survival of gastric cancer patients.

Mo H, Li P, Jiang S World J Surg Oncol. 2021; 19(1):256.

PMID: 34454511 PMC: 8403379. DOI: 10.1186/s12957-021-02366-4.

Assessment of the value of adjuvant radiotherapy for treatment of gastric adenocarcinoma based on pattern of post-surgical progression.

Wang P, Zhou H, Han G, Ni Q, Dai S, Huang J World J Surg Oncol. 2021; 19(1):205.

PMID: 34238296 PMC: 8268538. DOI: 10.1186/s12957-021-02304-4.

References

. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2016; 20(1):1-19. PMC: 5215069. DOI: 10.1007/s10120-016-0622-4. View

Hu Y, Huang C, Sun Y, Su X, Cao H, Hu J . Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial. J Clin Oncol. 2016; 34(12):1350-7. DOI: 10.1200/JCO.2015.63.7215. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1):7-30. DOI: 10.3322/caac.21590. View

Kodera Y, Yoshida K, Kumamaru H, Kakeji Y, Hiki N, Etoh T . Introducing laparoscopic total gastrectomy for gastric cancer in general practice: a retrospective cohort study based on a nationwide registry database in Japan. Gastric Cancer. 2018; 22(1):202-213. DOI: 10.1007/s10120-018-0795-0. View

Wohnrath D, Araujo R . Positive node-ratio in curative-intent treatment for gastric cancer is a strong independent prognostic factor for 5-year overall survival. J Surg Oncol. 2019; 121(5):777-783. DOI: 10.1002/jso.25755. View

Mitrousias A, Makris M, Zani S, Kornaropoulos M, Tsilimigras D, Chrysikos D . Laparoscopic versus open gastrectomy with D2 lymph node dissection for advanced gastric cancer: a systematic review. J BUON. 2019; 24(3):872-882. View

Katai H, Mizusawa J, Katayama H, Takagi M, Yoshikawa T, Fukagawa T . Short-term surgical outcomes from a phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer: Japan Clinical Oncology Group Study JCOG0912. Gastric Cancer. 2016; 20(4):699-708. DOI: 10.1007/s10120-016-0646-9. View

Liu F, Huang C, Xu Z, Su X, Zhao G, Ye J . Morbidity and Mortality of Laparoscopic vs Open Total Gastrectomy for Clinical Stage I Gastric Cancer: The CLASS02 Multicenter Randomized Clinical Trial. JAMA Oncol. 2020; 6(10):1590-1597. PMC: 7441466. DOI: 10.1001/jamaoncol.2020.3152. View

Shida D, Ochiai H, Tsukamoto S, Kanemitsu Y . Long-term outcomes of laparoscopic versus open D3 dissection for stage II/III colon cancer: Results of propensity score analyses. Eur J Surg Oncol. 2018; 44(7):1025-1030. DOI: 10.1016/j.ejso.2018.03.022. View

10.

Jung D, Son S, Park Y, Shin D, Ahn H, Ahn S . The learning curve associated with laparoscopic total gastrectomy. Gastric Cancer. 2014; 19(1):264-72. DOI: 10.1007/s10120-014-0447-y. View

11.

Kim H, Han S, Kim M, Kim W, Lee H, Ryu S . Effect of Laparoscopic Distal Gastrectomy vs Open Distal Gastrectomy on Long-term Survival Among Patients With Stage I Gastric Cancer: The KLASS-01 Randomized Clinical Trial. JAMA Oncol. 2019; 5(4):506-513. PMC: 6459124. DOI: 10.1001/jamaoncol.2018.6727. View

12.

Wang F, Shen L, Li J, Zhou Z, Liang H, Zhang X . The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer. Cancer Commun (Lond). 2019; 39(1):10. PMC: 6423835. DOI: 10.1186/s40880-019-0349-9. View

13.

Zong L, Abe M, Seto Y, Ji J . Randomized Controlled Trial of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: How Should We Define the Age of Included Patents?. J Clin Oncol. 2016; 34(30):3706. DOI: 10.1200/JCO.2016.68.2500. View

14.

Yu J, Huang C, Sun Y, Su X, Cao H, Hu J . Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial. JAMA. 2019; 321(20):1983-1992. PMC: 6547120. DOI: 10.1001/jama.2019.5359. View

15.

Mathis K, Nelson H . Controversies in laparoscopy for colon and rectal cancer. Surg Oncol Clin N Am. 2013; 23(1):35-47. DOI: 10.1016/j.soc.2013.09.006. View

16.

Lee H, Hyung W, Yang H, Han S, Park Y, An J . Short-term Outcomes of a Multicenter Randomized Controlled Trial Comparing Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy to Open Distal Gastrectomy for Locally Advanced Gastric Cancer (KLASS-02-RCT). Ann Surg. 2019; 270(6):983-991. DOI: 10.1097/SLA.0000000000003217. View

17.

Wong J . Effect of laparoscopic open distal gastrectomy on 3-year disease free survival in patients with locally advanced gastric cancer: commentary on the class-01 randomized clinical trial. Transl Gastroenterol Hepatol. 2019; 4:78. PMC: 6917552. DOI: 10.21037/tgh.2019.09.14. View

18.

. Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach. J Gastric Cancer. 2019; 19(1):1-48. PMC: 6441770. DOI: 10.5230/jgc.2019.19.e8. View

19.

Inaki N, Etoh T, Ohyama T, Uchiyama K, Katada N, Koeda K . A Multi-institutional, Prospective, Phase II Feasibility Study of Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection for Locally Advanced Gastric Cancer (JLSSG0901). World J Surg. 2015; 39(11):2734-41. DOI: 10.1007/s00268-015-3160-z. View

20.

Nakamura S, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K . Accurate Risk Stratification of Patients with Node-Positive Gastric Cancer by Lymph Node Ratio. World J Surg. 2020; 44(12):4184-4192. DOI: 10.1007/s00268-020-05739-0. View